From: Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis
p value | |
---|---|
CFU-ECs | |
Ps < vs. ≥ mean DOD | 0.15 |
PsA < vs. ≥ mean DOD | 0.72 |
Ps < vs. ≥ mean PASI | 0.94 |
PsA < vs. ≥ mean VAS | 0.84 |
Ps biological− vs. biological+ | 0.94 |
PsA biological− vs. biological+ | 0.16 |
Ps < vs. ≥ mean CRP | 0.53 |
PsA < vs. ≥ mean CRP | 0.87 |
CD133+/KDR+ cells (%) | |
Ps < vs. ≥ mean DOD | 0.23 |
PsA < vs. ≥ mean DOD | 0.65 |
Ps < vs. ≥ mean PASI | 0.66 |
PsA < vs. ≥ mean VAS | 0.11 |
Ps biological− vs. biological+ | 0.68 |
PsA biological− vs. biological+ | 0.58 |
Ps < vs. ≥ mean CRP | 0.65 |
PsA < vs. ≥ mean CRP | 0.24 |
PWV (m/s) | |
Ps < vs. ≥ mean DOD | 0.34 |
PsA < vs. ≥ mean DOD | 0.70 |
Ps < vs. ≥ mean PASI | 0.83 |
PsA < vs. ≥ mean VAS | 0.59 |
Ps biological− vs. biological+ | 0.51 |
PsA biological− vs. biological+ | 0.42 |
Ps < vs. ≥ mean CRP | 0.34 |
PsA < vs. ≥ mean CRP | 0.07 |
AIX | |
Ps < vs. ≥ mean DOD | 0.2 |
PsA < vs. ≥ mean DOD | 0.74 |
Ps < vs. ≥ mean PASI | 0.63 |
PsA < vs. ≥ mean VAS | 0.29 |
Ps biological− vs. biological+ | 0.09 |
PsA biological− vs. biological+ | 0.40 |
Ps < vs. ≥ mean CRP | 0.43 |
PsA < vs. ≥ mean CRP | 0.91 |